The high frequency of FASL+ CTCs or Treg cells and FAS+/CD8+ cytotoxic T or CD4+ T-helper cells in patients with breast cancer indicates that CTCs hinder the anti-tumor immune response through the FAS/FASL apoptotic pathway [85,86]. Here, CD8A is linked to neoplasm.